Erin VanDyke: Shifting Attention Upstream in VTE Care Through NBCA Centers of Excellence
Erin VanDyke, Vice President of National Blood Clot Alliance Centers of Excellence, shared a post on LinkedIn:
“Pulmonary embolism (PE) often takes the spotlight in venous thromboembolism (VTE) discussions, and understandably so—it is frequently life-threatening. But the most common precursor to PE is deep vein thrombosis (DVT), and this is where we have a real opportunity to intervene earlier.
- Up to 50% of patients with PE also have concomitant DVT
- An estimated 900,000 Americans are affected by VTE each year, with 100,000+ deaths annually—many preventable
Despite these numbers, resources and infrastructure to support DVT identification, follow-up, and longitudinal care remain limited compared to PE. Clinical pathways vary widely, and standardized approaches are often lacking.
National Blood Clot Alliance is leading national efforts across the full VTE disease state—PE and DVT alike. Through initiatives like the NBCA Centers of Excellence program, we are partnering with hospitals and clinical teams to:
- Standardize care protocols
- Strengthen follow-up pathways
- Provide education and resources that support providers and patients across the spectrum of VTE
We encourage centers to explore the NBCA COE program and stay tuned for new initiatives launching to support community DVT centers.
Our collective challenge—and opportunity—is to shift attention upstream. By addressing DVT earlier and more consistently, we can reduce downstream PE and ultimately save lives.”
More information here.
Keep up with Hemostasis Today.
-
Mar 15, 2026, 15:55Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 2
-
Mar 15, 2026, 14:09Abdul Mannan: A Red Eye, a Blood Clot, and Ibrutinib – The Clinical Tightrope
-
Mar 15, 2026, 14:02Denise M: Precision Hemostasis in Patient Blood Management
-
Mar 15, 2026, 13:57Abdulrahman Nasiri: D14 Bone Marrow Biopsy in AML Induction in the Era of Targeted Therapies
-
Mar 15, 2026, 13:52Valentin Ortiz-Maldonado: High-Impact Innovation in CAR-T Therapy Can Emerge From Academic Programmes
-
Mar 15, 2026, 13:45Tareq Abadl: Has Anyone Here Ever Taken an ALP Test Before?
-
Mar 14, 2026, 21:30Ayman Elbadawi: Why Does Stent Thrombosis Still Occur? Insights from the NCDR Data
-
Mar 14, 2026, 20:03Edward Adomako: Recognizing Thrombotic Thrombocytopenic Purpura as A Life-Threatening Emergency
-
Mar 14, 2026, 19:28Vishnu Priya Pulipati: Statins Beyond Cholesterol for Plaque Biology and Cardiovascular Risk Reduction